Third Quarter M&A Dealmaking May Indicate Gradual Return To Normalcy

 
• By Joseph Haas
  
M&A metrics increased during Q3 2025, according to Evaluate Pharma (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business